Therefore, we investigated the genetic and epigenetic relatedness of these malignancies with three objectives: First, we sought to investigate the presence of germline TSC1 and TSC2 mutations, to confirm whether both LAM and AML were sporadic or TSC-associated. The gene discussed is TSC1; the disease is lymphangioleiomyomatosis.